Histone deacetylase 2 (HDAC2) attenuates lipopolysaccharide (LPS)-induced inflammation by regulating PAI-1 expression
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Histone deacetylase 2 (HDAC2) attenuates lipopolysaccharide (LPS)-induced inflammation by regulating PAI-1 expression
Authors
Keywords
Histone deacetylase 2 (HDAC2), Plasminogen activator inhibitor (PAI), Lipopolysaccharide (LPS)
Journal
Journal of Inflammation-London
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-10
DOI
10.1186/s12950-018-0179-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HDAC2 Suppresses IL17A-Mediated Airway Remodeling in Human and Experimental Modeling of COPD
- (2018) Tianwen Lai et al. CHEST
- Plasminogen activator inhibitor-1 regulates macrophage-dependent postoperative adhesion by enhancing EGF-HER1 signaling in mice
- (2017) Kumpei Honjo et al. FASEB JOURNAL
- Ornithine decarboxylase regulates M1 macrophage activation and mucosal inflammation via histone modifications
- (2017) Dana M. Hardbower et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Plasminogen activator inhibitor-1 stimulates macrophage activation through Toll-like Receptor-4
- (2016) Kamlesh K. Gupta et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
- (2016) Mervyn Singer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Role of Plasminogen Activator Inhibitor Type-1 in Fibrosis
- (2016) Panagiotis Flevaris et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Neutrophil and Alveolar Macrophage-Mediated Innate Immune Control of Legionella pneumophila Lung Infection via TNF and ROS
- (2016) Pascal Ziltener et al. PLoS Pathogens
- Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease
- (2016) Fuqiang Wen et al. International Journal of Chronic Obstructive Pulmonary Disease
- Why a second look might be worth it: immuno-modulatory therapies in the critically ill patient
- (2016) Benedikt H. Siegler et al. Journal of Thoracic Disease
- Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer
- (2015) Satsuki Mashiko et al. CANCER BIOLOGY & THERAPY
- Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial
- (2015) Graham Devereux et al. Trials
- A Small Molecule Inhibitor to Plasminogen Activator Inhibitor 1 Inhibits Macrophage Migration
- (2013) Atsuhiko Ichimura et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The plasminogen activation system: new targets in lung inflammation and remodeling
- (2013) Michael Schuliga et al. CURRENT OPINION IN PHARMACOLOGY
- Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
- (2013) R. P. Dellinger et al. INTENSIVE CARE MEDICINE
- Severe Sepsis and Septic Shock
- (2013) Derek C. Angus et al. NEW ENGLAND JOURNAL OF MEDICINE
- TNF-α modulates statin effects on secretion and expression of MCP-1, PAI-1 and adiponectin in 3T3-L1 differentiated adipocytes
- (2012) Sylvia Madeira de Vergueiro Lobo et al. CYTOKINE
- Regulation of macrophage inflammatory protein-2 gene expression in response to 2,4-dinitrofluorobenzene in RAW 264.7 cells
- (2011) Dong-Bum Kim et al. BMB Reports
- REVIEW: Plasminogen Activator Inhibitor-1 (PAI-1): A Key Factor Linking Fibrinolysis and Age-Related Subclinical and Clinical Conditions
- (2010) Matteo Cesari et al. Cardiovascular Therapeutics
- The Surviving Sepsis Campaign: Results of an international guideline-based performance improvement program targeting severe sepsis*
- (2010) Mitchell M. Levy et al. CRITICAL CARE MEDICINE
- A Novel Inhibitor of Plasminogen Activator Inhibitor-1 Provides Antithrombotic Benefits Devoid of Bleeding Effect in Nonhuman Primates
- (2010) Yuko Izuhara et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Inhibition of histone deacetylase activity down-regulates urokinase plasminogen activator and matrix metalloproteinase-9 expression in gastric cancer
- (2010) Kyung Hee Lee et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Histone deacetylase inhibitor KBH-A42 inhibits cytokine production in RAW 264.7 macrophage cells and in vivo endotoxemia model
- (2009) Yongseok Choi et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Forced IFIT-2 expression represses LPS induced TNF-alpha expression at posttranscriptional levels
- (2008) Susanne Berchtold et al. BMC IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started